Spago Nanomedical genomför företrädesemission inför kliniska studier
Information & Documents
Issuer:
Spago Nanomedical AB
Chairman:
Eva Redhe
CEO:
Mats Hansen
Subscription period:
2017-10-04 - 2017-10-18
Issue size:
SEK 49m
Subscription price:
SEK 8.5 per share
Emissionsvolym:
48,7 MSEK + min 39 MSEK
Teckningskurs:
8,50 kr/unit
Värering (pre-money):
ca 73 MSEK
Teckningsåtaganden:
60 procent av initiala emissionsvolymen
Garantiåtaganden:
10 MSEK (toppgaranti)
Avstämningsdag:
29 september 2017
Lösenperiod teckningsoptioner:
11 mars - 22 mars 2019
Get notified
Do you want to get email notifications about upcoming transactions? Let us know at emissioner@redeye.se
Access our tools & Data
Get your hands on the same professional tools and data that our analyst team use for creating the best return on investment. Sign up for our Premium and access it all today:
All our tools and data included
From 349 SEK / Month Cancel any time